Unknown

Dataset Information

0

ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.

ABSTRACT: Background:We adopted ABVD chemotherapy with risk-adapted radiation therapy (RT) as first-line therapy for children, adolescents and young adults with Hodgkin lymphoma (HL) in British Columbia in 2004. Patients and methods:Patients ? 25 years diagnosed from 2004 to 2013 with all stages of HL who received ABVD as initial therapy were included. Results:Among 55 children (age?

SUBMITTER: Marr KC 

PROVIDER: S-EPMC5834115 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.

Marr K C KC   Connors J M JM   Savage K J KJ   Goddard K J KJ   Deyell R J RJ  

Annals of oncology : official journal of the European Society for Medical Oncology 20170401 4

<h4>Background</h4>We adopted ABVD chemotherapy with risk-adapted radiation therapy (RT) as first-line therapy for children, adolescents and young adults with Hodgkin lymphoma (HL) in British Columbia in 2004.<h4>Patients and methods</h4>Patients ≤ 25 years diagnosed from 2004 to 2013 with all stages of HL who received ABVD as initial therapy were included.<h4>Results</h4>Among 55 children (age < 18 year) and 154 young adults (18-25 year), there were no significant differences among age groups f  ...[more]

Similar Datasets

Unknown ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
| S-EPMC8084804 | biostudies-literature
Unknown Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
| S-EPMC3359734 | biostudies-literature
Unknown The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD.
| S-EPMC5767288 | biostudies-other
Unknown A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity.
| S-EPMC3833204 | biostudies-other
Unknown ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
| S-EPMC3932020 | biostudies-literature
Unknown ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma.
| S-EPMC7284091 | biostudies-literature
Unknown Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
| S-EPMC3359733 | biostudies-literature
Unknown Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective Study.
| S-EPMC7990646 | biostudies-literature
Unknown A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.
| S-EPMC4633349 | biostudies-literature
Unknown Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
| S-EPMC3641323 | biostudies-literature